[1]
A. Siltari, “Testosterone replacement therapy is not associated with increased prostate cancer incidence, prostate cancer-specific, or cardiovascular disease-specific mortality in Finnish me”, AO, vol. 62, no. 12, pp. 1898–1904, Dec. 2023.